COLYTE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Colyte, and what generic alternatives are available?
Colyte is a drug marketed by Norvium Bioscience and is included in one NDA.
The generic ingredient in COLYTE is polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous. There are four hundred and twenty-one drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for COLYTE?
- What are the global sales for COLYTE?
- What is Average Wholesale Price for COLYTE?
Summary for COLYTE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 328 |
| Clinical Trials: | 6 |
| Patent Applications: | 2,446 |
| Drug Prices: | Drug price information for COLYTE |
| What excipients (inactive ingredients) are in COLYTE? | COLYTE excipients list |
| DailyMed Link: | COLYTE at DailyMed |
Recent Clinical Trials for COLYTE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Incheon St.Mary's Hospital | Phase 3 |
| Seoul National University Hospital | Phase 3 |
| Inje University | N/A |
